Interest in biomarkers has exploded in recent years, driven by improvements in data collection and analysis, burgeoning interest in personalized medicine, and efforts to increase the success rate for ...
Please provide your email address to receive an email when new articles are posted on . ADx NeuroSciences and Alamar Biosciences have announced a partnership to develop customized biomarker assays for ...
Please provide your email address to receive an email when new articles are posted on . The in vitro immunoassay is being developed by Roche in partnership with Eli Lilly & Co. Blood-based biomarker ...
The SPEAR UltraDetect ™ Nf-L Biomarker Assay Kit enables quantification of neurofilament light with ultra-high precision, minimal sample volume, and a straightforward, wash-free workflow. The assay ...
BD-pTau 217 is a refined biomarker which enhances Alzheimer’s specificity while retaining the strengths of plasma pTau 217.
GENT, Belgium & FREMONT, Calif.--(BUSINESS WIRE)--ADx NeuroSciences, a wholly owned subsidiary of Fujirebio and a leader in neurodegenerative disease biomarker development, and Alamar Biosciences, a ...
Cancer biomarkers span a broad biological spectrum, including proteins, metabolites, and nucleic acids detectable in samples such as tissue biopsies and blood. 1 At the beginning of a biomarker ...
Glial fibrillary acidic protein (GFAP), a blood biomarker, can be used to rapidly distinguish between hemorrhagic and ischemic stroke, according to a new prospective study. The hope, researchers say, ...
The advent of multiomic approaches has significantly improved early cancer detection by integrating diverse molecular data to gain a more complete understanding of disease processes. While advances in ...
Using chromatography-based analysis, researchers demonstrate how complementary alcohol biomarkers can help distinguish between recent binge drinking and repeated alcohol consumption in forensic ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results